Ignota Labs Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$7.85M
- Investors
-
16
Ignota Labs General Information
Description
Developer of medical technology designed to optimize the drug discovery process, eliminating compounds harmful to the environment and minimizing waste. The company's platform uses artificial intelligence algorithms to predict toxic endpoints, earlier in the drug discovery process, enabling the pharmaceutical industry to be more sustainable by reducing environmental damage and improving drug safety.
Contact Information
Website
www.ignotalabs.aiCorporate Office
- Saint Johns Innovation Centre, Saint Johns Innovation Park
- Cowley Road
- Cambridge CB4 0WS
- England, United Kingdom
Corporate Office
- Saint Johns Innovation Centre, Saint Johns Innovation Park
- Cowley Road
- Cambridge CB4 0WS
- England, United Kingdom
Ignota Labs Timeline
Ignota Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 27-Feb-2025 | $7.85M | Completed | Generating Revenue | ||
| 5. Grant | 28-Jan-2025 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-May-2024 | Completed | Generating Revenue | |||
| 3. Equity Crowdfunding | 24-Oct-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Oct-2023 | $65.2K | $479K | Completed | Generating Revenue | |
| 1. Seed Round | 13-Sep-2023 | $414K | $414K | Completed | Product Development |
Ignota Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 Preferred | ||||||||
| Seed-2 Preferred | ||||||||
| Seed-1 Preferred | ||||||||
| Ordinary | 102,362 | $0.000001 | $3.54 | $3.54 | 1x | $3.54 | 4.58% | |
| Ordinary | 303,521 | $0.000001 | $1.35 | $1.35 | 1x | $1.35 | 13.57% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ignota Labs Patents
Ignota Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250188084-A1 | Compounds and methods for modulating cdk9 activity | Pending | 05-Nov-2020 | ||
| US-11339168-B2 | Crystalline forms of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as syk inhibitors | Active | 22-Feb-2019 | ||
| US-20230098309-A1 | Crystalline forms of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[l,2-a]pyrazin-8-amine as syk inhibitors | Active | 22-Feb-2019 | ||
| US-12152037-B2 | Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a syk inhibitor | Active | 22-Feb-2019 | ||
| US-20200291035-A1 | Solid forms of a syk inhibitor | Active | 22-Feb-2019 | C07D487/04 |
Ignota Labs Signals
Ignota Labs Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AIX Ventures | Venture Capital | Minority | ||
| ARTIS (San Francisco) | Venture Capital | Minority | ||
| Blue Wire Capital | Venture Capital | Minority | ||
| Fiddlehead Ventures | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority |
Ignota Labs Investments (1)
Ignota Labs’s most recent deal was a Corporate Asset Purchase with Kronos Bio (Clinical Pipeline Assets). The deal was made on 06-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kronos Bio (Clinical Pipeline Assets) | 06-Oct-2025 | Corporate Asset Purchase | Buildings and Property |
Ignota Labs FAQs
-
When was Ignota Labs founded?
Ignota Labs was founded in 2021.
-
Where is Ignota Labs headquartered?
Ignota Labs is headquartered in Cambridge, United Kingdom.
-
What is the size of Ignota Labs?
Ignota Labs has 9 total employees.
-
What industry is Ignota Labs in?
Ignota Labs’s primary industry is Drug Discovery.
-
Is Ignota Labs a private or public company?
Ignota Labs is a Private company.
-
What is the current valuation of Ignota Labs?
The current valuation of Ignota Labs is .
-
What is Ignota Labs’s current revenue?
The current revenue for Ignota Labs is .
-
How much funding has Ignota Labs raised over time?
Ignota Labs has raised $8.68M.
-
Who are Ignota Labs’s investors?
AIX Ventures, ARTIS (San Francisco), Blue Wire Capital, Fiddlehead Ventures, and Gaingels are 5 of 16 investors who have invested in Ignota Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process